Sg 109, sold under the brand name Soma, has been identified as Carisoprodol 350 mg, used to treat musculoskeletal pain. It belongs to a class of drugs called skeletal muscle relaxants. The drug was approved for medical use in the United States in 1959. Carisoprodol is categorized as a schedule IV controlled substance under the Controlled Substance Act (CSA). ScieGen Pharmaceuticals, Inc. supply this medication.










